BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15585426)

  • 1. Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia.
    Ford K; Wirawan DN; Sumantera GM; Sawitri AA; Stahre M
    AIDS Educ Prev; 2004 Dec; 16(6):487-98. PubMed ID: 15585426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV testing experience of drug users in Bali, Indonesia.
    Sagung Sawitri AA; Sumantera GM; Wirawan DN; Ford K; Lehman E
    AIDS Care; 2006 Aug; 18(6):577-88. PubMed ID: 16831786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia: factors associated with condom use during the last sexual intercourse.
    Kumar MS; Virk HK; Chaudhuri A; Mittal A; Lewis G
    Int J Drug Policy; 2008 Apr; 19(2):148-58. PubMed ID: 18221862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using lay counsellors to promote community-based voluntary counselling and HIV testing in rural northern Ghana: a baseline survey on community acceptance and stigma.
    Baiden F; Akanlu G; Hodgson A; Akweongo P; Debpuur C; Binka F
    J Biosoc Sci; 2007 Sep; 39(5):721-33. PubMed ID: 17207292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV testing and disclosure: a qualitative analysis of TB patients in South Africa.
    Daftary A; Padayatchi N; Padilla M
    AIDS Care; 2007 Apr; 19(4):572-7. PubMed ID: 17453600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to undergo HIV testing among factory workers in Surabaya, Indonesia.
    Sasaki Y; Arifin A; Ali M; Kakimoto K
    AIDS Care; 2011 Oct; 23(10):1305-13. PubMed ID: 21547754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug users talk about HIV testing: motivating and deterring factors.
    Downing M; Knight K; Reiss TH; Vernon K; Mulia N; Ferreboeuf M; Carroll A; Vu C
    AIDS Care; 2001 Oct; 13(5):561-77. PubMed ID: 11571004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fear of stigmatization as barrier to voluntary HIV counselling and testing in South Africa.
    Meiberg AE; Bos AE; Onya HE; Schaalma HP
    East Afr J Public Health; 2008 Aug; 5(2):49-54. PubMed ID: 19024410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The depiction of stigmatization in research about hepatitis C.
    Paterson BL; Backmund M; Hirsch G; Yim C
    Int J Drug Policy; 2007 Oct; 18(5):364-73. PubMed ID: 17854724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-related knowledge and stigma--United States, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Dec; 49(47):1062-4. PubMed ID: 11186610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing.
    Maman S; Mbwambo J; Hogan NM; Kilonzo GP; Sweat M
    AIDS Care; 2001 Oct; 13(5):595-603. PubMed ID: 11571006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voluntary counselling and testing sites as a source of sentinel information on HIV prevalence in a concentrated epidemic: a pilot project from Indonesia.
    Guy R; Mustikawati DE; Wijaksono DB; Nugraihini N; Priohutomo S; Silitonga N; Kaldor JM
    Int J STD AIDS; 2011 Sep; 22(9):505-11. PubMed ID: 21890546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-related stigma, service utilization, and status disclosure among truck drivers crossing the Southern borders in Brazil.
    Pulerwitz J; Michaelis AP; Lippman SA; Chinaglia M; Díaz J
    AIDS Care; 2008 Aug; 20(7):764-70. PubMed ID: 18767210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influencing factors for seeking HIV voluntary counseling and testing among tuberculosis patients in Cambodia.
    Yi S; Poudel KC; Yasuoka J; Ichikawa M; Tan V; Jimba M
    AIDS Care; 2009 Apr; 21(4):529-34. PubMed ID: 19401868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptance and disclosure of HIV status through an integrated community/home-based care program in South Africa.
    Ncama BP
    Int Nurs Rev; 2007 Dec; 54(4):391-7. PubMed ID: 17958669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African countries.
    Dlamini PS; Kohi TW; Uys LR; Phetlhu RD; Chirwa ML; Naidoo JR; Holzemer WL; Greeff M; Makoae LN
    Public Health Nurs; 2007; 24(5):389-99. PubMed ID: 17714223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam.
    Tran TM; Nguyen HT; Yatsuya H; Hamajima N; Nishimura A; Ito K
    BMC Public Health; 2006 Oct; 6():248. PubMed ID: 17029648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive and negative consequences of HIV disclosure among seropositive injection drug users.
    Parsons JT; VanOra J; Missildine W; Purcell DW; Gómez CA
    AIDS Educ Prev; 2004 Oct; 16(5):459-75. PubMed ID: 15491957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study.
    Demas P; Schoenbaum EE; Wills TA; Doll LS; Klein RS
    AIDS Educ Prev; 1995 Oct; 7(5):429-42. PubMed ID: 8672395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
    Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
    AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.